Thursday, 28 January 2016

Pharma packaging: Counterfeiting remains a menace


Pharma packaging firm Schott Kaisha’s Managing Director Kairus Dadachanji sees a need for the country to provide a push to the primary packaging segment as well as address the menace of counterfeiting.

“The most important thing the nation needs to address is counterfeit,” he declared, pointing out how it remained an issue despite packaging being made more difficult to copy.

The company is working with the office of the Drug Controller General and the Organisation of Pharmaceutical Producers of India to evolve ways and means to tackle the menace. Underscoring the need to be more strict, he favored a check by the USFDA. Primary packaging is not under the purview of FDA presently and the pharmaceutical companies did the audit, he said.

Mr. Dadachanji was in Hyderabad recently for a seminar the company had organised on latest trends and developments in the pharma packaging.

“The drug authorities in India and abroad explicitly require that pharmaceutical companies manage risks more closely, as patient safety is of utmost importance”, he told the seminar.

Companies like Schott Kaisha, which is an Indo-German joint venture, were morphing into solutions rather than remaining as mere suppliers. They work as partners with pharma companies “from concept to commercialisation,” he said. Such an approach is also driven by the emerging competition. “We are seeing companies absent in India for so many years suddenly seeing interest in India... [they] want to be here and coming,” he said.

Schott Kaisha is a leading supplier to the pharmaceutical industry for a range of small volume tubular glass parenteral packaging, including ampoules, vials, cartridges and sterile prefillable glass syringes.

It exports about 25 per cent of the production, particularly large volumes to South Africa and Mexico. It has manufacturing facilities at Jambusar in Gujarat and Daman, with a total annual capacity of 2.5 billion pieces, and giving shape to expansion plans. 

Source: http://www.thehindu.com/news/cities/Hyderabad/pharma-packaging-counterfeiting-remains-a-menace/article8158396.ece

Monday, 25 January 2016

Pharma academic research - Indian patent applications published on 22nd January 2016

Every week of thousands of patent applications are published in India. The patent applications filed by the pharma academic research institutes in India go un-noticed.

We publish a list of Indian applications published related to pharma academics. This would provide us an idea about the kind of academic research being carried out in these institutes. For details of these patents, please write back to us at pharmaliterati@gmail.com


Invention
Application No
Inventors
Institute
Isolation process for novel biopolymer from the fruit pulp of ficus carica and its inbuilt pharmaceutical bio-excipient property
1965/DEL/2014A
1) Dr. N V Satheesh Madhav
2) Abhay Pratap Yadav
DIT University, Dehradun
Novel combination kit for treatment of malaria
1983/DEL/2014A
1) Renu Tripathi
2) Prabhat Ranjan Mishra
3) Pankaj Dwivedi
4) Hemlata Dwivedi
5) Sunil Kumar Singh
6) Sunil Kumar Puri
7) Anil Kumar Dwivedi
Council of Scientific & Industrial Research
Novel series of alkoxyphenylcarboxamido derivatives-II
2298/MUM/2014A
1) Sharma Manish
2) Malik Ruchi
B R Nahata College of Pharmacy, Mandsaur, Madhya Pradesh.
Development of an effective herbal drug formulation for the treatment of sickle cell anaemia and the process thereof
2948/MUM/2009A
1) Vinod Domaji Rangari
2) Virendra Sukhadeo Borkar
3) Anwar Siraj Daud
4) Showkat Ahmad Patni
5) Jayant Janrao Thakre
6) Milind Pandurang Mane
Not known
Novel 2-substituted thaizole compounds
2294/MUM/2014A
1) Kamala Kunju Vasu
2) Vasudevan Sudarsanam
3) Dhaivatkumar Harikrishnabhai Pandya
4) Jayesh Anilkumar Sharma
5) Manish Nivsarkar
B.V. Patel Pharmaceutical Education and Research Development (PERD) Center, Ahmedabad, Gujarat
(5-thiazolyl/thienyl)-2-thienyl methanones
2295/MUM/2014A
1) Kamala Kunju Vasu
2) Vasudevan Sudarsanam
3) Jayesh Anilkumar Sharma
4) Dhaivatkumar Harikrishnabhai Pandya
5) Milee Agarwal
6) Sneha Patel
7) Shaikh Muhammad Vaseem
8) Ravat Nirav Mineshkumar
B.V. Patel Pharmaceutical Education and Research Development (PERD) Center, Ahmedabad, Gujarat
Method and device for determining vitamin B12 deficiency
2577/CHE/2014A
1) Tulasi Kota Karanth
2) Sowmyashree Kota Karanth
3) Dr. Veena Kota Laxminarayan Karanth
Manipal University
Isolating and identifying the active constituent of ethyl acetate leaf extract of Alpinia Purpurata, being a constituent for the treatment of ovarian cancer
2751/CHE/2014A
1) Dr. V.K. Gopalakrishnan
2) Dr. C. Arul Raj

Department of Biochemistry,
Karpagam University, Coimbatore.
Isolation and characterization of active constituent from Tylophora Pauciflora, being a component for the treatment of prostate cancer
2752/CHE/2014A
1) Dr. V.K. Gopalakrishnan
2) Mr. T. Starlin
Department of Biochemistry,
Karpagam University, Coimbatore.
Isolating and identifying the active constituent of ethanolic extract of Cayratia Irifolia, being a constituent for the treatment of ovarian cancer
2753/CHE/2014A
1) Dr. V.K. Gopalakrishnan
2) Mr. P. Chella Perumal
Department of Biochemistry,
Karpagam University, Coimbatore.
Isolating and identifying the active constituent from the ethanolic leaf extract of Barleria Cristata L, being a constituent for the treatment of diabetes
2754/CHE/2014A
1) Dr. K. Devaki
2) Dr. R. Naramadha
Department of Biochemistry,
Karpagam University, Coimbatore.
Isolating and identifying the active constituent form the ethanolic extract of Ananus Comosus (L.) merr peel, being a constituent for the treatment of mammary cancer
2755/CHE/2014A
1) Dr. K. Devaki
2) Dr. C. Uma
3) Dr. M. Kalaiselvi
Department of Biochemistry,
Karpagam University, Coimbatore.
A process for isolation and identification of bioactive compound from Streptomyces Cavouresis KUV39, being a constituent for the treatment of cervical cancer
2756/CHE/2014A
1) Dr. Rajeshwari Sivaraj
2) S. Narendhran
3) P. Rajiv
4) P. Vanathi
Department of Biotechnology,
Karpagam University, Coimbatore.
Characterization of potential antidiabetic compound from Padina Boergesen II Allender and kraft and its effect on streptozotocin induced diabetic rats
2757/CHE/2014A
1) Dr. S. Sudha
2) P. Senthilkumar
Department of Biotechnology,
Karpagam University, Coimbatore.


Friday, 22 January 2016

Savitribai Phule Pune University sponsored seminars

Smt. Kashibai Navale College of Pharmacy, Kondhwa (Bk.) Pune is organizing various seminars sponsored by Savitribai Phule Pune University.

Event
Dates
Convenor
Email
Must Know Regulations for Pharma Professional
29th & 30th  January  2016
Dr. M. P. Mahajan,
(Mobile: 9850273807)

Pharmacoeconomics & Emerging Career Opportunities
6th February 2016
Dr. S. S. Pawar,
(Mobile: 9822962721)

New Horizons & advances in Formulation Development of
New Dosage Forms
12th  & 13th February 2016
Dr. (Mrs) J. R. Madan, (Mobile: 9420148817)


http://www.sinhgad.edu/PDF/SKNCOP_Seminars_announcement.pdf


Thursday, 21 January 2016

Pharma academic research - Indian patent applications published on 15th January 2016

Every week of thousands of patent applications are published in India. The patent applications filed by the pharma academic research institutes in India go un-noticed.

We publish a list of Indian applications published related to pharma academics. This would provide us an idea about the kind of academic research being carried out in these institutes. For details of these patents, please write back to us at pharmaliterati@gmail.com

Invention
Application No.
Inventors
Institute
15th  January 2016
Nitrite reductase (NIRB) as potential anti tubercular target and a method to detect the severity of tuberculosis disease
7488/DELNP/2015A
1) Sarkar Dhiman
CSIR
An ophthalmic topical composition of a vasodilator
2199/MUM/2014A
1) Dr. Kothari R.S.
Not known
System and method for measuring permeability of drugs/toxic chemical compounds
2550/CHE/2014A
1) S. Harshal
2) Mukesh Doble
Indian Institute Of Technology, Madras
Drug delivery formulation of rapamycin in the form of polymeric nanoparticles for cancer therapy
8/KOL/2011A
1) Sanjeeb Kumar Sahoo
2) Priyambada Parhi
3) Chandana Mohanty
Institute of department of Biotechnology, Government of India, Bhubaneswar.

1st convention of ISPOR, "Concept & role of pharmacoeconomics & outcomes research in healthcare



National Seminar on "Current perspectives on drug safety and pharmacovigilance




Friday, 15 January 2016

British drug maker AstraZeneca may launch innovative drugs in India


British drug maker AstraZeneca is betting big on Asia, including emerging markets such as India where it plans to introduce innovative products in its focus areas of cancer, lung diseases and diabetes rather than depend on generic drugs.

The company, which warded off a takeover bid from Pfizer last year, is reposing faith in its new drug pipeline to grow in India even as other multinational drug firms complain about lack of intellectual property protection in the country.

“There is a high unmet medical need in the South Asia healthcare landscape. Patients are not getting treated with guidelines that are recommended. So, we want to be in the whole healthcare ecosystem that we, as pharma companies, can be part of,” said Joris Silon, AstraZeneca's vice-president for Asia. “The key areas for us in India would be diabetes, asthma, respiratory diseases and oncolog” he said.

The intense competition in India's diabetes market has not deterred the company from expanding its predominant presence. It sees a recent court ruling that shot down a compulsory licence request by an Indian company for its diabetes drug Onglyza as a shot in the arm for its India operations. “We want to do a sustainable business in India. If we define something, we need to have long term planning. If regulations move in different directions it is not easy for us. So, India is an important market for us, because of the huge unmet medical needs and the huge size of the population, and I do believe with this court ruling that things are moving in the right direction,” said Silon. He said the company is working with regulators and governments to make sure there is right ecosystem. “So, having IP which is respected and a good stable regulatory environment is one of them. It might be a bumpy road, but we will continue to work” he said.

In the diabetes market, though, the next focus for the company will be its new drug Forxiga, a new class of drug which the company feels will be the future in this therapy. Silon said it is looking for a marketing partner for Forxiga who is “trustworthy, sustainable and has high ethical standards“. AstraZeneca's India business is one of the smallest among prominent foreign firms, but the company has one of the highest growth rates. It has sales of 586 crore with a 14.5% growth rate, according to data from the All India Organisation of Chemists and Druggists Association.

Details: http://economictimes.indiatimes.com/articleshow/50570344.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

Tuesday, 12 January 2016

Exploring the opportunities and challenges in drug delivery technologies and its pharmacokinetics


Vivekanand Education Society's College of Pharmacy, Mumbai is organizing one day symposium and poster competition on, “Exploring the opportunities and challenges in drug delivery technologies and its pharmacokinetics”.
  
Date:             13th February, 2016.
Venue:           Vivekanand Education Society’s College Of Pharmacy, Mumbai.
Theme:        Exploring the opportunities and challenges in drug delivery technologies and its pharmacokinetics.

Abstracts should be mailed by 15th January 2016 at vescopseminar2016@gmail.com

One Day Seminar On “Tropical Diseases: Challenges and Advances”

Vivekanand Education Society's College of Pharmacy, Mumbai is organizing One Day Seminar On “Tropical Diseases: Challenges and Advances”.

The objective of this seminar is to generate awareness, curiosity, sense of responsibility and to develop a research aptitude in the said areas among pharmacy professionals. Medical practitioners and researchers will be sharing their experiences on drug designing & development and clinical aspects of tropical diseases, which will surely enlighten the audience with better understanding of these diseases.

The details for the same are as follows:

Date:               Saturday, 16th January, 2016.
Topic:              One Day Seminar On “Tropical Diseases: Challenges and Advances”.




Pharma academic research - Indian patent applications published on 8th January 2016

Every week of thousands of patent applications are published in India. The patent applications filed by the pharma academic research institutes in India go un-noticed.

We publish a list of Indian applications published related to pharma academics. This would provide us an idea about the kind of academic research being carried out in these institutes. For details of these patents, please write back to us at pharmaliterati@gmail.com

Invention
Application No.
Inventors
Institute
8th  January 2016
Instrument for measuring learning ability and spatial memory of laboratory animals
4127/DEL/2015A
1) Prof.(Dr.) Milind Parle
2) Ms.Sushila Kaura
3) Ms.Monu
Guru Jambheshwar University of Science and Technology, Hisar, Haryana.
Acetylcholinesterase (AChE) inhibitors coated nanoparticles conjugates
2164/MUM/2014A
1) Kinnari Harsumanbhai Parekh
2) Nidhi Pankajkumar Parikh
3) Anuradha Sujai Joshi
Charotar University of Science & Technology, Anand, Gujarat
Methanolic extract and different fractions of bryonopsis laciniosa for diabetes mellitus in diabetic rats
2341/CHE/2014A
1) Dr. Goverdhan Puchchakayala
2) Dr. Krishna Mohan Gottumukkal
Ethnopharmacology Lab, University College of Pharmaceutical Sciences, Kakatiya University, Warangal.
Synthesis of diethyl (3-chloro-6, 7-difluoro-1h-thiazolo [3, 4-A] quinoxalin-1-ylidene) malonate
2411/CHE/2014A
1) Dr. Manohar. P. Shinhasan
Not known
Methanolic extract and different fractions of muntingia calabura for diabetes mellitus in diabetic rats
2309/CHE/2014A
1) Dr. Goverdhan Puchchakayala
2) Dr. Krishna Mohan Gottumukkal
Ethnopharmacology Lab, University College of Pharmaceutical Sciences, Kakatiya University, Warangal.
Methanolic extract and different fractions of cipadessa baccifera for diabetes mellitus in diabetic rats
2340/CHE/2014A
1) Dr. Goverdhan Puchchakayala
2) Dr. Krishna Mohan Gottumukkal
Ethnopharmacology Lab, University College of Pharmaceutical Sciences, Kakatiya University, Warangal.